FRANKLIN RESOURCES INC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
Franklin Resources Inc. is a holding company that, when grouped with its various subsidiaries, is also known as Franklin Templeton Investments. The company was founded in 1847 by Rupert Johnson, Sr., who named the company after Benjamin Franklin because he wanted the company values to reflect Franklin’s “ideas of frugality and prudence when it came to saving and investing.” His son, Charles Johnson, would take over as CEO in 1957, slowly building the company until it went public in 1971, giving the company enough capital to facilitate growth. Just two years later, it would acquire Winfield & Company, bringing total assets under management to close to a quarter billion. Franklin Money Fund, the company’s first billion-dollar fund, would be launched in 1979, reflecting tremendous growth that would continue through the 1980s. From just 1982 to 1987, the assets under management for Franklin would grow from $2 billion to over $40 billion with a heavy emphasis on fixed income investments, which management would address. The 1990s would mark a period of diversification, expanding globally throughout Europe and Asia. In 1992, the company acquired Templeton, Galbraith & Hansberger Ltd., leading to the same of Franklin Templeton. Today the company specializes in conservatively managed mutual funds, offering products under Franklin, Templeton, Mutual Series and Fiduciary. It has over 200 different mutual funds, some notable ones including the Templeton Growth Fund, Mutual Shares Fund, Mutual Discovery Fund. And Templeton Growth (Euro) Fund A. Franklin Resources now has over 8 thousand employees all around the globe with offices in 35 countries and clients in over 150 countries, generating revenues of over $8 billion with total assets from over 25 million private, professional, and institutional investors amounting to over $15 billion. In 2013, the chairman Charlie Johnson retired with Greg Johnson replacing him to become the chairman and CEO.
As of the latest 13F report, the guru’s equity portfolio contained 2285 stocks valued at a total of $190.50Bil. The top holdings were MSFT(3.36%), AAPL(1.67%), and AMZN(1.48%).
According to GuruFocus data, these were FRANKLIN RESOURCES INC’s top five trades of the quarter.
NextEra Energy Inc
FRANKLIN RESOURCES INC reduced their investment in NYSE:NEE by 21,658,135 shares. The trade had a 0.9399999999999999% impact on the equity portfolio. During the quarter, the stock traded for an average price of $80.78.
On 02/10/2023, NextEra Energy Inc traded for a price of $74.92 per share and a market cap of $148.88Bil. The stock has returned 1.47% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, NextEra Energy Inc has a price-earnings ratio of 35.78, a price-book ratio of 3.80, a EV-to-Ebitda ratio of 22.35 and a price-sales ratio of 7.12.
The price-to-GF Value ratio is 0.82, earning the stock a GF Value rank of 9.
ArcLight Clean Transition Corp
The guru established a new position worth 30,690,894 shares in NAS:ACTCU, giving the stock a 0.36% weight in the equity portfolio. Shares traded for an average price of $21.2 during the quarter.
On 02/10/2023, ArcLight Clean Transition Corp traded for a price of $21.2 per share and a market cap of $0.00Mil. The stock has returned 0.00% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, ArcLight Clean Transition Corp has a price-earnings ratio of 9999.00.
Bristol-Myers Squibb Co
FRANKLIN RESOURCES INC reduced their investment in NYSE:BMY by 5,957,437 shares. The trade had a 0.23% impact on the equity portfolio. During the quarter, the stock traded for an average price of $75.40000000000001.
On 02/10/2023, Bristol-Myers Squibb Co traded for a price of $72.125 per share and a market cap of $153.35Bil. The stock has returned 11.79% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Bristol-Myers Squibb Co has a price-earnings ratio of 24.45, a price-book ratio of 4.69, a price-earnings-to-growth (PEG) ratio of 3.06, a EV-to-Ebitda ratio of 9.62 and a price-sales ratio of 3.32.
The price-to-GF Value ratio is 0.95, earning the stock a GF Value rank of 6.
JPMorgan Chase & Co
During the quarter, FRANKLIN RESOURCES INC bought 3,264,482 shares of NYSE:JPM for a total holding of 15,027,879. The trade had a 0.23% impact on the equity portfolio. During the quarter, the stock traded for an average price of $126.71.
On 02/10/2023, JPMorgan Chase & Co traded for a price of $140.48 per share and a market cap of $412.21Bil. The stock has returned -7.37% over the past year.
GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 6 out of 10.
In terms of valuation, JPMorgan Chase & Co has a price-earnings ratio of 11.63, a price-book ratio of 1.56, a price-earnings-to-growth (PEG) ratio of 1.74 and a price-sales ratio of 3.24.
The price-to-GF Value ratio is 0.97, earning the stock a GF Value rank of 6.
Merck & Co Inc
FRANKLIN RESOURCES INC reduced their investment in NYSE:MRK by 4,263,655 shares. The trade had a 0.2% impact on the equity portfolio. During the quarter, the stock traded for an average price of $102.22.
On 02/10/2023, Merck & Co Inc traded for a price of $108.44 per share and a market cap of $274.94Bil. The stock has returned 45.23% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Merck & Co Inc has a price-earnings ratio of 18.99, a price-book ratio of 6.18, a price-earnings-to-growth (PEG) ratio of 2.50, a EV-to-Ebitda ratio of 14.39 and a price-sales ratio of 4.66.
The price-to-GF Value ratio is 1.01, earning the stock a GF Value rank of 6.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
